Bal Pharma raises funds via preferential issue

Bal Pharma raises funds via preferential issue. Proceeds from the preferential issue will be utilized for general corporate purposes. The filing indicates no immediate equity dilution for public shareholders. Details on amount and pricing are yet to be disclosed.

📊 STOCKS: $BALPHARMA | 🏢 SECTOR: Pharma | #LOWIMPACT #Funding